Ventora Medical

After completing the Melbourne Accelerator Program (MAP) Velocity Program in 2019, Ventora Medical had the pleasure of exhibiting at this year's MAP Demo Day at Marvel Stadium's Medallion Club. It was inspiring to hear the pitches from this year’s impressive MAP cohort, showcasing their achievements and valuable learnings gained from the accelerator program. The event brought together a passionate community of innovators and provided a fantastic opportunity to share Ventora Medical's progress since completing the Velocity program, reconnect with familiar faces and build exciting new relationships. We are grateful for the continued support from the Melbourne Entrepreneurial Centre at the University of Melbourne, particularly from Melbourne Accelerator Program (MAP) and Translating Research at Melbourne.

Last week, our co-founders Amy Yu and Christiane Theda, travelled to Brisbane for the 2024 BridgeTech Program Symposium at QUT Gardens Point. The BridgeTech Program is part of the medtech commercialisation training supported by MTPConnect’s Clinical Translation & Commercialisation Medtech (CTCM) program, of which Ventora was a round 2 recipient. The symposium event covered essential topics including product development pathways, TGA regulatory requirements and financing strategies for medtech innovations, as well as interesting insights looking into the future of healthcare. During their visit to Brisbane, Amy and Christiane also had the privilege of visiting the Mater Mother’s Hospital to meet with neonatologist Dr Friederike Beker. This was a valuable opportunity to demonstrate Ventora's prototype device and obtain important clinical feedback.

Ventora Medical has just been awarded $50k in funding through LaunchVic’s Medtech Market Growth Program (MMGP). Delivered through a collaboration between LaunchVic and the Department of Jobs, Skills, Industry and Regions, the MMGP aims to support Victorian scaling medtech startups accelerate their pathway to market. This MMGP Grant will support Ventora to expand internal engineering and quality capabilities and will contribute towards product refinement and market research activities. For more information, visit: https://lnkd.in/gYae2gUY

Our co-founder Amy Yu joined Caroline Duell on the MTPConnect podcast at the CTCM (Clinical Translation and Commercialisation Medtech) Program Symposium. Check out the podcast episode to hear more about the CTCM Round 2 awardee projects and how the CTCM Program has been able to support Ventora Medical's commercialisation journey. Listen here: https://lnkd.in/gWG5Vz2M

Last week our co-founder, Associate Professor Christiane Theda, had the privilege of presenting the topic “Cool new tools in the NICU” at the 2023 Cool Topics in Neonatology conference. The conference, curated to present the latest in newborn research, brought together 250 clinicians and researchers from Australia and New Zealand, who are all dedicated to advancing the best-practice care for ill or prematurely born babies. Christiane shared some insights into Ventora's development and current research aimed at improving non-invasive respiratory support for newborns and more broadly, the medical device development and commercialisation process. Cool Topics 2023 provided an excellent platform to exchange ideas with experts and learn about exciting developments in neonatology. #NeonatalResearch #CoolTopics2023

November 17th marks World Prematurity Day, a day to recognise and raise awareness of the global challenges associated with premature birth. Each year, 15 million premature babies are born worldwide. Premature birth results in an increased risk of life-threatening complications, developmental challenges and life-long health problems, placing immense stress on affected families and creating a substantial financial burden on healthcare systems. At Ventora, we are committed to providing healthcare professionals with the tools necessary to optimise respiratory care and improve outcomes for our tiniest patients. On this day, let’s reflect on the strength and resilience of premature infants and their families. We express gratitude for the incredible strides made in neonatal care thus far and look forward to contributing to the standard of care of the future. #WorldPrematurityDay #NICUCare

The Ventora Medical team recently travelled to Sydney to participate in the CTCM (Clinical Translation and Commercialisation Medtech) Symposium, organised by MTPConnect. The symposium brought together round 1 and round 2 CTCM awardees, along with partners and supporters of the program. It was great to hear more about the innovative projects of fellow CTCM awardees and how each project will positively impact patients’ lives. Round 1 awardees also generously shared valuable insights and lessons from their journey. As part of the CTCM program’s value-add opportunities, the Ventora team also had the privilege to attend the Medical Technology Association of Australia (MTAA) Medtech Conference at ICC Sydney. The conference gathered industry and thought leaders in medical technology, facilitating discussions on the opportunities, challenges and future of this dynamic field. It was an inspiring two days for the Ventora team, reinforcing our commitment to advancing healthcare through innovation and ensuring that we remain at the forefront of industry trends and developments. #MedTech23 #CTCM Edward Buijs Amy Yu Christiane Theda Alan Haszard Hebbat Manhy Stuart Anderson Danielle Shand Andionne Parlade